Evidence map›Paper›PMID 22886607›Full record

ArticleSurgery today2013

Management of postoperative hemorrhage associated with factor VIII inhibitor: report of a case.

Ichiro Onishi, Masato Kayahara, Masayoshi Munemoto, Seisyo Sakai, Isamu Makino, Hironori Hayashi, Hisatoshi Nakagawara, Hidehiro Tajima, Hiroyuki Takamura, Hirohisa Kitagawa and 2 more

Open access · greenAbstract readCase Reports
PubMed Publisher
In one paragraph

Article in Surgery today, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 2 syntheses or guidelines pooled it, 16 citations in OpenAlex.

  1. Rituximab for eradicating inhibitors in people with acquired haemophilia A.The Cochrane database of systematic reviews · 2021
    Pooled it
  2. Rituximab for eradicating inhibitors in people with acquired haemophilia A.The Cochrane database of systematic reviews · 2016
    Pooled it
  3. Acquired hemophilia A secondary to cholangiocarcinoma: A case report and literature review.Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences · 2025
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Acquired hemophilia A as a cause of recurrent bleeding into the pleural cavity - case report and literature review.Kardiochirurgia i torakochirurgia polska = Polish journal of cardio-thoracic surgery · 2014
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Ichiro OnishiDepartment of Gastroenterologic Surgery, Division of Cancer Medicine, Graduate School of Medical Science, Kanazawa University, 13-1 Takara-machi, Kanazawa, Ishikawa 920-8641, Japan. ionishi@kinbyou.hosp.go.jp
Masato Kayahara
Masayoshi Munemoto
Seisyo Sakai
Isamu Makino
Hironori Hayashi
Hisatoshi Nakagawara
Hidehiro Tajima
Hiroyuki Takamura
Hirohisa Kitagawa
Takashi Tani
Tetsuo Ohta
Kanazawa University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This report presents a case that was successfully treated for acquired factor VIII inhibitor after extensive visceral surgery. A 71-year-old male who underwent surgery for bile duct cancer had active bleeding in the abdominal drainage tube on postoperative day (POD) 5, and prolonged activated partial thromboplastin time (aPTT) was detected (83.1 s) on POD 7. An extensive coagulation work-up revealed factor VIII deficiency (1 %), and a diagnosis of an acquired factor VIII deficiency was established when a factor VIII inhibitor of 8 Bethesda units was demonstrated. The patient was treated with activated prothrombin complex concentrate (aPCCs) and bloody discharge was stopped within 3 days. Inhibitor elimination was started using prednisolone on POD 20; rituximab, was administered on POD 74 and 81. Factor VIII inhibitor had disappeared by POD 124, and factor VIII (72 %) and aPTT recovered to 45.9 s. This case report demonstrated the efficacy of aPCCs and rituximab in the treatment of acquired hemophilia associated with visceral surgery.

Indexed as

AgedAntibodies, Monoclonal, Murine-DerivedBile Duct NeoplasmsBiomarkersBlood Coagulation Factor InhibitorsBlood Coagulation FactorsFactor VIIIHemophilia AHumansMalePartial Thromboplastin TimePostoperative CarePostoperative ComplicationsPostoperative HemorrhageRituximabTime FactorsAntibodies, Monoclonal, Murine-DerivedBiomarkersBlood Coagulation Factor InhibitorsBlood Coagulation FactorsFactor VIIIprothrombin complex concentratesRituximab

Identifiers

PMID22886607
OpenAlexW2048127843

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.